Twitter Linkedin-in

Biologics Series

27 - 29 April 2020 | London, UK
Book Now
Biologics Series27 - 29 April 2020 | London, UK

Join over 450 leaders, experts and scientists at the UK’s largest Biologics forum, connecting global pharma, biotech and academia to advance next generation biotherapeutics

Download Agenda
Register

The Biologics Series features 3 outstanding programmes bringing together Europe’s most successful protein, antibody, peptide and bispecific experts under one roof.

The event includes over 120 cutting-edge presentations and workshops, over 8 hours of valuable networking sessions, and an exhibition hall showcasing 50 vendor companies.

Programmes

Proteins & Antibodies

An industry-leading programme offering abundant learning, knowledge-sharing & partnership building opportunities in protein & antibody engineering, biotherapeutics development and bioanalysis.

Peptides & Oligonucleotides

Bringing together leaders from across the industry, the event features unparalleled opportunities to discuss, debate and hear from the latest peptides research, from manufacturing, chemistry & analytical technologies through to therapeutics success stories; together with insights into oligonucleotide research.

Bispecifics in Discovery & Development

In line with current industry trends, our new event will address the latest advancements in bispecifics discovery, therapeutic development and application.

Key Speakers

The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Robin Löving

Robin Löving

Chief Scientific Officer
Salipro Biotech
Zhimei Du

Zhimei Du

Director
MSD
colette-johnston

Colette Johnston

Senior Director, Early Discovery
Crescendo Biologics
Henrik Sune Ramírez-Andersen

Henrik Sune Ramírez-Andersen

Scientific Director
Novo Nordisk A/S
Laura Lin

Laura Lin

Executive Director, Biomedical Design
Pfizer
Tristan Vaughan

Tristan Vaughan

Vice President R&D, Antibody Discovery & Protein Engineering
AstraZeneca

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall
Submit Abstract

Welcome Reception

Join us after the opening keynotes that close our first day for an evening of fun, drinks & chat!
Enquire

Kick-Off Sessions

Launching the event in 2020 is a new range of closed-door interactive sessions covering the key focus areas in Biologics research
Find Out More

Event App

Helping you get more from the event with networking features, searchable presentations & attendees, and much more
Read More

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
“I liked the mix of presentation topics, and the quality of the talks. The size of the meeting was good, as was the networking time"
Vice President InnovationDuPont
"Topics were of high interest. I liked the opportunity to network and interact with key industry partners. Great presentations - fantastic learning opportunity."
ScientistSanofi
"The event was well organized, with a great line of prominent and knowledgeable speakers.I liked that there was also enough time for networking."
Senior Vice President, Drug DiscoveryTaros
"The talks were a very high quality and had some excellent feedback. The lunch was good and the layout made people interact."
Sales ManagerFortéBio Biologics
"The 8+ hours of networking time allowed optimal time for discussions linked with the pre-organised meetings."
Inside Sales ManagerBio-Techne
Previous
Next
Biologics Post-Event Report
Biologics 2019 Post-Event Report
Statistics, feedback, photos and more from last year's event.
Abcam Webinar
Complimentary Webinar
Abcam's VP New Product Development, Alejandra Solache: Antibody selection and enhanced validation strategies webinar
Thomas Novo Nordisk
Bioconjugation and New Target Discovery
Q&A with Novo Nordisk's Scientific Director, Thomas Hoeg-Jensen
Zealand Webinar
Complimentary Webinar
From Andy Parker, Senior Vice President & Chief Scientific Officer, Zealand Pharma: From Peptide Discovery to Phase 3 – A Zealand Perspective
Tony Evox
Q&A Session with Antonin De Fougerolles
Chief Executive Officer of Evox Therapeutics, Antonin De Fougerolles: The Role of Bispecific Antibodies within the Healthcare Industry
Content Hub Graphic
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.